Delivery Order SPE2DB22D2009-SPE2DB25FL9RL
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $6,110.42 and is a firm fixed-price, non-set-aside contract with a period of performance ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 10 mg tablets, a diabetes medication. The contract has a ceiling value of $2,758.78 and a completion date of June 23, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 10 mg tablets, a diabetes medication, with a ceiling value of $26,869.70 and a performance period ending on June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $17,247.05 and a period of performance through July 8, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $2,055.50 and a completion date of April 18, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The award has a ceiling value of $15,251.32 and is a firm fixed price contract with an ultimate completion date of July 8, 2025. The contract is not a set-aside award, indicating open competition. Amerisourcebergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a firm fixed price pricing type, a ceiling value of $16,301.28, and a period of performance ending on July 10, 2025. The contract is not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a ceiling value of $4,409.61 and a period of performance through April 29, 2025. It is a firm fixed-price contract, and no set-aside designation is mentioned, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $14,553.13 and an ultimate completion date of January 5, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The delivery order has a ceiling value of $39,227.80 and a completion date of June 5, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp also...